Skip to main content
. 2017 Jan 1;7(1):9–22. doi: 10.7150/thno.16042

Figure 7.

Figure 7

In vivo antitumor therapeutic efficacy with PC-3 tumor bearing mice. (a) Therapeutic regimens for anti-VEGF therapy by siVEGF in combination with photothermal therapy with laser or HIFU. (b) Tumor growth rate graph and (c, d) images at Day 12, 16 and 30 in all tested experimental groups. ** P<0.005 (n=4)